Modalis Therapeutics Corporation (TYO:4883)
Japan
· Delayed Price · Currency is JPY 76.00
+2.00 (2.70%)
May 30, 2025, 3:30 PM JST
Modalis Therapeutics Market Cap
Modalis Therapeutics has a market cap or net worth of 5.70 billion as of May 30, 2025. Its market cap has increased by 110.85% in one year.
Market Cap
5.70B
Enterprise Value
2.14B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
76.00
Market Cap Chart
Since August 3, 2020, Modalis Therapeutics's market cap has decreased from 60.66B to 5.70B, a decrease of -90.61%. That is a compound annual growth rate of -38.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2025 | 5.55B | -21.66% |
| Dec 30, 2024 | 7.08B | 80.79% |
| Dec 29, 2023 | 3.92B | -59.92% |
| Dec 30, 2022 | 9.77B | -44.97% |
| Dec 30, 2021 | 17.75B | -71.83% |
| Dec 30, 2020 | 63.03B | 3.92% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.51T |
| Daiichi Sankyo Company | 7,106.35B |
| Takeda Pharmaceutical Company | 6,603.45B |
| HOYA Corporation | 6,143.70B |
| Terumo | 4,013.34B |
| Otsuka Holdings | 3,584.41B |
| Astellas Pharma | 2,514.21B |
| Shionogi & | 2,031.86B |